References
- Alvarez C, Cremades N, Blasco N, et al. Influence of gonadotropin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization. Hum Reprod 1997;12:2366–9
- Chang SY, Lee CL, Wang ML, et al. No detrimental effects in delaying initiation of gonadotropin administration after pituitary desensitization with gonadotropin-releasing hormone agonist. Fertil Steril 1993;59:183–6
- Damario MA, Moomjy M, Tortoriello D, et al. Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone agonist (GnRH-a) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates. Fertil Steril 1997;68:1004–10
- Antoine JM, Salat-Baroux J, Alvarez S, et al. Ovarian stimulation using human menopausal gonadotropins with or without LHRH analogues in a long protocol for in-vitro fertilization: a prospective randomized comparison. Hum Reprod 1990;5:565–9
- Damario MA, Moomjy M, Tortoriello D, et al. Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone agonist (GnRH-a) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates. Fertil Steril 1997;68:1004–10
- Golan A, Weissman A. Symposium: update on prediction and management of OHSS. A modern classification of OHSS. Reprod Biomed Online 2009;19:28–32
- Ravhon A, Aurell R, Lawrie H, et al. The significance of delayed suppression using buserelin acetate and recombinant follicle-stimulating hormone in a long protocol in vitro fertilization program. Fertil Steril 2000;73:325–9
- Dessolle L, Ferrier D, Colombel A, et al. Prolonging GnRH-agonist to achieve ovarian suppression does not compromise the results of a long protocol. Eur J Obstet Gynecol Reprod Biol 2011;159:111–4
- Calhaz-Jorge C, Leal F, Cordeiro I, et al. Pituitary down-regulation in IVF cycles: is it necessary to use strict criteria? J Assist Reprod Genet 1995;12:615–9
- Hughers EG, Fedorkow DM, Daya S, et al. The routine use of gonadotropin releasing hormone agonists prior to in vitro fertilization and gamete intra fallopian transfer: a meta-analysis of randomized studies. Fertil Steril 1992;58:888–96
- Scott RT, Hayslip CA, Neal GS, et al. The duration of leuprolide acetate administration prior to ovulation induction does not impact ovarian responsiveness to exogenous gonadotropins. Fertil Steril 1993;60:247–53
- Seifer DB, Thornton KL, DeCherney AH, Lavy G. Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success. Fertil Steril 1991;56:500–4
- Polan ML, Daniele A, Russel JB, DeCherney AH. Ovulation induction with human menopausal gonadotropin compared to urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa–luteal cell function. J Clin Endocrinol Metab 1986;63:1284–91
- Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 2002;17:3129–37